Skip to content

DiRx Appoints Ben Maizel as Chief Operating Officer

Monroe, New Jersey, October 1, 2020

DiRx Inc., an emerging digital health company, announced today that Ben Maizel has joined the company as its Chief Operating Officer (COO). He will oversee operations and customer service.

Ben's professional background spans an illustrious 40 years, covering all aspects of commercialization and distribution in the pharmaceutical industry.

Starting his career in retail pharmacy, Ben transitioned to wholesale business, where he launched one of the first private label generic pharmaceutical lines in the U.S. He has held sales leadership roles for Taro Pharmaceuticals and Alpharma, where he built and led national sales and marketing groups, and was President of Rouses Point Pharmaceuticals. He later established and ran RxTPL, the third-party logistics division of Masters Pharmaceuticals, as its President until its acquisition by McKesson Corporation, and he continued to be associated with it until earlier this year.

Ben also has experience in medical advertising and specialty pharma repackaging and helped launch or reset multiple pharmaceutical companies as well as brand and generic products as an independent consultant. Some of his clients included Reliant Pharmaceuticals, Endo, Eisai, Triax, Akrimax, Rouses Point, Epic, and Edenbridge.

Ben graduated from the University of Florida with a degree in Business and earned his Masters from Fairleigh Dickenson University.

"With Ben joining the DiRx leadership team, we have our operations placed in seasoned hands," said Satish Srinivasan, CEO of DiRx. "While growing up in the industry, I've always had the highest degree of respect for Ben's track record, accomplishments and industry reputation, and I'm so delighted that Ben was able to identify with DiRx's vision and agreed to join our team."

"I'm excited about our mission to get people their needed medications and bring cost out of the system," said Ben.

About the Company

Headquartered in Monroe, New Jersey, DiRx is a new type of digital pharmacy that is designed to deliver significant savings to consumers on most commonly prescribed, FDA-approved, generic medications delivered to their doorstep on a recurring subscription model. Envisioned by a team of experienced health care leaders whose goal is to put consumers first and enhance affordability, DiRx's service will be available on a cash-only subscription basis, without insurance.

For more information:

Phone: 908.356.0764